Rock Inhibitor Netarsudil for the Management of Glaucoma: EXPERT INSIGHTS AND CASE STUDY REVIEWS
August 05, 2020
Aerie Pharmaceuticals convened a group of expert thought leaders in the diagnosis and management of glaucoma to share their insights and experience with Rhopressa® and Rocklatan®, using case studies of patients in their practices as examples, including such topics as the rationale for treatment, efficacy and safety outcomes, ideal candidates for therapy, and managing patient expectations.